Amarin Corporation
AMRN
#7762
Rank
โ‚ฌ0.29 B
Marketcap
14,21ย โ‚ฌ
Share price
0.49%
Change (1 day)
53.45%
Change (1 year)

Revenue for Amarin Corporation (AMRN)

Revenue in 2025 (TTM): โ‚ฌ0.20 Billion

According to Amarin Corporation 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.19 Billion. In 2024 the company made a revenue of โ‚ฌ0.21 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amarin Corporation from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.20 B-7.71%
2024 โ‚ฌ0.21 B-20.87%
2023 โ‚ฌ0.27 B-19.34%
2022 โ‚ฌ0.34 B-33.16%
2021 โ‚ฌ0.51 B3.15%
2020 โ‚ฌ0.49 B30.14%
2019 โ‚ฌ0.38 B91.47%
2018 โ‚ฌ0.20 B32.75%
2017 โ‚ฌ0.15 B22.05%
2016 โ‚ฌ0.12 B65.4%
2015 โ‚ฌ74.77 M67.78%
2014 โ‚ฌ44.56 M133.57%
2013 โ‚ฌ19.08 M
2012 N/A
2011 N/A
2010 N/A
2003 -โ‚ฌ11.94 Million-119.05%
2002 โ‚ฌ62.66 M2.92%
2001 โ‚ฌ60.88 M223.41%
2000 โ‚ฌ18.82 M
1998 โ‚ฌ15.92 M-20.92%
1997 โ‚ฌ20.14 M5.29%
1996 โ‚ฌ19.12 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚ฌ51.22 B 26,205.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.92 B 25,536.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
โ‚ฌ1.30 B 570.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 18,579.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 7,298.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel